Development of a novel long-lived immunoPET tracer for monitoring lymphoma therapy in a humanized transgenic mouse model.
about
Multiscale Framework for Imaging Radiolabeled TherapeuticsTripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B.Imaging of hepatocellular carcinoma patient-derived xenografts using ⁸⁹Zr-labeled anti-glypican-3 monoclonal antibody.Radiation Dosimetry Study of [(89)Zr]rituximab Tracer for Clinical Translation of B cell NHL Imaging using Positron Emission Tomography.Performance of 89Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell LymphomaEngineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo.(89)Zr, a radiometal nuclide with high potential for molecular imaging with PET: chemistry, applications and remaining challenges.Zirconium-89 labeled antibodies: a new tool for molecular imaging in cancer patients.Current advances in ligand design for inorganic positron emission tomography tracers (68)Ga, (64)Cu, (89)Zr and (44)Sc.Lymphoma: current status of clinical and preclinical imaging with radiolabeled antibodies.Single cell imaging of Bruton's tyrosine kinase using an irreversible inhibitor.Evaluation of 89Zr-rituximab tracer by Cerenkov luminescence imaging and correlation with PET in a humanized transgenic mouse model to image NHL.ImmunoPET of Malignant and Normal B Cells with 89Zr- and 124I-Labeled Obinutuzumab Antibody Fragments Reveals Differential CD20 Internalization In Vivo.Development of Novel ImmunoPET Tracers to Image Human PD-1 Checkpoint Expression on Tumor-Infiltrating Lymphocytes in a Humanized Mouse Model.Evaluation of Next-Generation Anti-CD20 Antibodies Labeled with Zirconium 89 in Human Lymphoma Xenografts.
P2860
Q27301080-9EB041CB-BD4B-43C9-B6C4-013572354939Q35170338-39D11EE9-A6C8-4BCF-8C8E-47423556BB4CQ35187951-0FCC2246-871E-4E83-9960-1C446C8E211DQ35736289-449ADE53-016F-4B10-9956-086B7AA57647Q36242716-39B00929-F294-4D8B-ADBC-40E0524D95F7Q37519517-B220EE0F-025F-43EE-A067-4D9E1896059BQ38111973-1D0C28A3-024F-4826-A029-93CB776C34D3Q38225877-DCCDD900-0EAD-4240-87B7-8524CE5ACEFCQ38729041-616158DE-0066-449C-A4B6-089B9CE46CD3Q38795442-8FB3EB3E-0CF3-437E-801F-BF7BB7699E1EQ38938436-7922CBE8-7A69-4929-BF4E-77AACAD06619Q39183420-677F2B97-D37F-4351-B55C-025902FFD6B3Q46060208-6F67FA59-CA30-4BAD-9FA7-139D34779B76Q47100953-D5BF063F-9779-4AED-A4A5-C180AA90BF06Q49953473-C6AA0287-55E0-4B29-B92F-E9BD3E878005
P2860
Development of a novel long-lived immunoPET tracer for monitoring lymphoma therapy in a humanized transgenic mouse model.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Development of a novel long-li ...... anized transgenic mouse model.
@ast
Development of a novel long-li ...... anized transgenic mouse model.
@en
type
label
Development of a novel long-li ...... anized transgenic mouse model.
@ast
Development of a novel long-li ...... anized transgenic mouse model.
@en
prefLabel
Development of a novel long-li ...... anized transgenic mouse model.
@ast
Development of a novel long-li ...... anized transgenic mouse model.
@en
P2093
P2860
P356
P1476
Development of a novel long-li ...... anized transgenic mouse model.
@en
P2093
Arutselvan Natarajan
Frezghi Habte
Sanjiv S Gambhir
P2860
P304
P356
10.1021/BC300039R
P577
2012-06-11T00:00:00Z